Home » Topics » BioWorld Science

BioWorld Science
RSS

Researchers identify GNMT as potential therapeutic target in UC and RCC

June 1, 2018

Nektar Therapeutics submits NDA to the FDA for NKTR-181

June 1, 2018

Signs of clinical efficacy seen with HPV-specific T-cell therapy

June 1, 2018

Doptelet becomes available in the U.S. for the treatment of thrombocytopenia

June 1, 2018

Cortexyme announces USD 76 million financing and provides update on COR-388 clinical progress

June 1, 2018

Phase II study of MGL-3196 in NASH achieves liver biopsy endpoints at 36 weeks

June 1, 2018

Astellas submits application for marketing approval of peficitinib in Japan

June 1, 2018

Impel NeuroPharma initiates phase IIa trial of INP-103 in Parkinson's disease OFF episodes

June 1, 2018

FDA grants fast track designation for fimepinostat in relapsed or refractory DLBCL

June 1, 2018

Xencor opens enrollment in phase I study of XmAb-20717 for advanced solid tumors

June 1, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...